Vacarean-Trandafir I, Amarandi R, Ivanov I, Dragos L, Mentel M, Iacob S
Front Cell Infect Microbiol. 2025; 14:1468645.
PMID: 39872941
PMC: 11770057.
DOI: 10.3389/fcimb.2024.1468645.
Sankarasubramanian J, Ahmad R, Avuthu N, Singh A, Guda C
Front Med (Lausanne). 2020; 7:606298.
PMID: 33330572
PMC: 7729129.
DOI: 10.3389/fmed.2020.606298.
Li Y, Xu H, Xu T, Xiao M, Tang H, Wu D
Dig Dis Sci. 2018; 63(11):3074-3083.
PMID: 30094621
PMC: 6182452.
DOI: 10.1007/s10620-018-5230-1.
Kim D, Cho J, Yang H
Pediatr Gastroenterol Hepatol Nutr. 2018; 21(1):43-50.
PMID: 29383304
PMC: 5788950.
DOI: 10.5223/pghn.2018.21.1.43.
Cappella M, Pugliese F, Zucchini A, Marchetti F
Case Rep Pediatr. 2016; 2016:1591753.
PMID: 27190666
PMC: 4850252.
DOI: 10.1155/2016/1591753.
The impact of Clostridum difficile on surgical rate among ulcerative colitis patients: A systemic review and meta-analysis.
Peng J, Shen J, Zhu Q, Ran Z
Saudi J Gastroenterol. 2015; 21(4):208-12.
PMID: 26228363
PMC: 4542418.
DOI: 10.4103/1319-3767.161644.
Epidemiology and risk factors for IBD.
Ananthakrishnan A
Nat Rev Gastroenterol Hepatol. 2015; 12(4):205-17.
PMID: 25732745
DOI: 10.1038/nrgastro.2015.34.
Vitamin D deficiency is associated with community-acquired clostridium difficile infection: a case-control study.
Sahay T, Ananthakrishnan A
BMC Infect Dis. 2014; 14:661.
PMID: 25471926
PMC: 4258019.
DOI: 10.1186/s12879-014-0661-6.
Environmental risk factors for inflammatory bowel diseases: a review.
Ananthakrishnan A
Dig Dis Sci. 2014; 60(2):290-8.
PMID: 25204669
PMC: 4304948.
DOI: 10.1007/s10620-014-3350-9.
Emergence of fecal microbiota transplantation as an approach to repair disrupted microbial gut ecology.
Khoruts A, Weingarden A
Immunol Lett. 2014; 162(2 Pt A):77-81.
PMID: 25106113
PMC: 5554112.
DOI: 10.1016/j.imlet.2014.07.016.
Higher plasma vitamin D is associated with reduced risk of Clostridium difficile infection in patients with inflammatory bowel diseases.
Ananthakrishnan A, Cagan A, Gainer V, Cheng S, Cai T, Szolovits P
Aliment Pharmacol Ther. 2014; 39(10):1136-42.
PMID: 24641590
PMC: 4187206.
DOI: 10.1111/apt.12706.
Reset of a critically disturbed microbial ecosystem: faecal transplant in recurrent Clostridium difficile infection.
Fuentes S, van Nood E, Tims S, Heikamp-de Jong I, Ter Braak C, Keller J
ISME J. 2014; 8(8):1621-33.
PMID: 24577353
PMC: 4817604.
DOI: 10.1038/ismej.2014.13.
Treatment of relapsing Clostridium difficile infection using fecal microbiota transplantation.
Pathak R, Enuh H, Patel A, Wickremesinghe P
Clin Exp Gastroenterol. 2014; 7:1-6.
PMID: 24421645
PMC: 3881092.
DOI: 10.2147/CEG.S53410.
Surgical Management of Clostridium difficile Colitis.
Seltman A
Clin Colon Rectal Surg. 2013; 25(4):204-9.
PMID: 24294121
PMC: 3577611.
DOI: 10.1055/s-0032-1329390.
Genetic risk factors for Clostridium difficile infection in ulcerative colitis.
Ananthakrishnan A, Oxford E, Nguyen D, Sauk J, Yajnik V, Xavier R
Aliment Pharmacol Ther. 2013; 38(5):522-30.
PMID: 23848254
PMC: 3755009.
DOI: 10.1111/apt.12425.
Fecal microbiota transplantation in relapsing Clostridium difficile infection.
Rohlke F, Stollman N
Therap Adv Gastroenterol. 2012; 5(6):403-20.
PMID: 23152734
PMC: 3491681.
DOI: 10.1177/1756283X12453637.
Predictors of severe outcomes associated with Clostridium difficile infection in patients with inflammatory bowel disease.
Ananthakrishnan A, Guzman-Perez R, Gainer V, Cai T, Churchill S, Kohane I
Aliment Pharmacol Ther. 2012; 35(7):789-95.
PMID: 22360370
PMC: 3716251.
DOI: 10.1111/j.1365-2036.2012.05022.x.
Microbial induction of immunity, inflammation, and cancer.
Greer J, OKeefe S
Front Physiol. 2011; 1:168.
PMID: 21423403
PMC: 3059938.
DOI: 10.3389/fphys.2010.00168.
Clostridium difficile infection: epidemiology, risk factors and management.
Ananthakrishnan A
Nat Rev Gastroenterol Hepatol. 2010; 8(1):17-26.
PMID: 21119612
DOI: 10.1038/nrgastro.2010.190.